Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

mammography

  • You have access
    Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer
    Yubei Huang, Huan Wang, Zhangyan Lyu, Hongji Dai, Peifang Liu, Ying Zhu, Fengju Song and Kexin Chen
    Cancer Biology & Medicine September 2022, 19 (9) 1375-1384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0758
  • You have access
    Interpretation of breast cancer screening guideline for Chinese women
    Yubei Huang, Zhongsheng Tong, Kexin Chen, Ying Wang, Peifang Liu, Lin Gu, Juntian Liu, Jinpu Yu, Fengju Song, Wenhua Zhao, Yehui Shi, Hui Li, Huaiyuan Xiao and Xishan Hao
    Cancer Biology & Medicine November 2019, 16 (4) 825-835; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0322
  • You have access
    Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?
    Nehmat Houssami
    Cancer Biology & Medicine February 2017, 14 (1) 1-8; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0050
  • You have access
    Is the BI-RADS Categorization Valuable for Nonpalpable Breast Lesions in Chinese Women?
    Zhongzhao Wang, Baoning Zhang, Jing Li and Liming Jiang
    Chinese Journal of Clinical Oncology December 2005, 2 (6) 856-860;

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire